ResearcherShanghai Medical College of Fudan UniversityActive in the last 2 years
Ke Zhang
Matched on ORCID iD 0009-0002-9053-4278; OpenAlex author ID A5100365765. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 2, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 20
2019: 1 paper · 2020: none · 2021: 2 papers · 2022: 1 paper · 2023: 2 papers · 2024: 2 papers
Papers 8
- KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression. Co-author DOI 10.1016/j.prp.2023.155046↗
- EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic Adenocarcinoma. Co-author DOI 10.31083/j.fbl2903119↗
- Revealing platelet-related subtypes and prognostic signature in pancreatic adenocarcinoma. Co-author DOI 10.1186/s12920-023-01530-x↗
- [Progressin Tumor-Associated Macrophages in the Treatment of Pancreatic Cancer]. Co-author DOI 10.3881/j.issn.1000-503x.15282↗
- Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer. Co-author DOI 10.1186/s12920-022-01246-4↗
- Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway. First author DOI 10.1016/j.lfs.2021.119205↗
- NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response. First author DOI 10.3389/fcell.2021.641836↗
- Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine resistance in pancreatic cancer via upreg… Co-author DOI 10.18632/aging.102307↗
Closest collaborators
The 20 strongest of 20 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Zhen Chen · 4 shared papers, 2019–2024 · strength 0.75
- Paper Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer. DOI 10.1186/s12920-022-01246-4↗
- Paper KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression. DOI 10.1016/j.prp.2023.155046↗
- Paper EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic A… DOI 10.31083/j.fbl2903119↗
- Yanhua Jing · 3 shared papers, 2022–2024 · strength 0.66
- Paper Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer. DOI 10.1186/s12920-022-01246-4↗
- Paper KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression. DOI 10.1016/j.prp.2023.155046↗
- Paper EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic A… DOI 10.31083/j.fbl2903119↗
- Fengjiao Wang · 3 shared papers, 2022–2024 · strength 0.66
- Paper Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer. DOI 10.1186/s12920-022-01246-4↗
- Paper KIF20B and MET, hub genes of DIAPHs, predict poor prognosis and promote pancreatic cancer progression. DOI 10.1016/j.prp.2023.155046↗
- Paper EIF2Ss, a Novel c-Myc-Correlated Gene Family, is Associated with Poor Prognosis and Immune Infiltration in Pancreatic A… DOI 10.31083/j.fbl2903119↗
- Zhangqi Cao · 2 shared papers, 2024 · strength 0.43
- Juying Jiao · 2 shared papers, 2024 · strength 0.43
- Chien‐shan Cheng · 2 shared papers, 2024 · strength 0.43
- Linjie Ruan · 2 shared papers, 2024 · strength 0.43
- Yongqiang Hua · 3 shared papers, 2019–2021 · strength 0.39
- Paper Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway. DOI 10.1016/j.lfs.2021.119205↗
- Paper NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolde… DOI 10.3389/fcell.2021.641836↗
- Paper Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine r… DOI 10.18632/aging.102307↗
- Zhouyu Ning · 3 shared papers, 2019–2021 · strength 0.39
- Paper Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway. DOI 10.1016/j.lfs.2021.119205↗
- Paper NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolde… DOI 10.3389/fcell.2021.641836↗
- Paper Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine r… DOI 10.18632/aging.102307↗
- Hao Chen · 2 shared papers, 2019–2023 · strength 0.31
- Weidong Shi · 2 shared papers, 2021 · strength 0.30
- Paper Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway. DOI 10.1016/j.lfs.2021.119205↗
- Paper NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolde… DOI 10.3389/fcell.2021.641836↗
- Meiyu Peng · 1 shared paper, 2023 · strength 0.24
- Luming Liu · 2 shared papers, 2019–2021 · strength 0.24
- Paper Fam83D promotes tumorigenesis and gemcitabine resistance of pancreatic adenocarcinoma through the Wnt/β-catenin pathway. DOI 10.1016/j.lfs.2021.119205↗
- Paper Long non-coding SBF2-AS1 acting as a competing endogenous RNA to sponge microRNA-142-3p to participate in gemcitabine r… DOI 10.18632/aging.102307↗
- Linjia Peng · 1 shared paper, 2023 · strength 0.22
- Jiangang Zhao · 1 shared paper, 2023 · strength 0.22
- Yujie Li · 1 shared paper, 2023 · strength 0.22
- Ye Li · 1 shared paper, 2021 · strength 0.15
- Ye Li · 1 shared paper, 2021 · strength 0.15
- Luming Liu · 1 shared paper, 2021 · strength 0.15
- Zhiqiang Meng · 1 shared paper, 2019 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.